As it stands, 95% of clinical supply managers say that they face some level of supply risk in their trials due to drug shortages or distribution issues. What’s more, supply challenges typically lead to delays anywhere between two and four months.

Over the next 10 years, increased expectations for accelerated clinical timelines, severe shortages of manufacturing resources and the increased manufacturing complexity and cost of biologics will all lead to even more bottlenecking in the drug supply chain. This infographic explains how purpose-built waste reduction solutions — along with an efficient reallocating of saved drugs — can accelerate timelines, alleviate bottleneck issues and save money. These types of solutions allow for:

• Accurate and robust forecasting that factor in all complex, moving parts
• Optimization of supply and manufacturing strategies to reduce drug waste
• Real-time trial data monitoring that allows for reaction to potential risks

​